Medical Device News Magazine

Clinical Evaluation Report Template: A Free Resource for Medical Device Manufacturers

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Clinical Evaluation Report

By Ramya Sriram

Open talent platform Kolabtree has announced the release of an expert-sourced Clinical Evaluation Report template to help medical device manufacturers meet EU MDR requirements. The template aims to make it easier for medtech businesses to understand what they need in order to achieve compliance required for their products to be placed in the European market.

What is a CER? 

The clinical evaluation report (CER) provides clinical data to support the clinical safety and efficacy of a device. It assesses the clinical risks associated with the use of a device, its expected clinical performance in an intended population and any contraindications for use. The clinical evaluation requirements and processes are outlined in Article 61 and Annex XIV of the EU MDR. A CER is submitted when a clinical study is conducted in support of an application for a marketing authorization. The report provides reasonable assurance that the device complies with all applicable requirements; this includes both legal and technical requirements.

The CER forms part of the Technical File and allows devices access into Europe if compliant. Approved devices get the coveted CE Mark that certifies that the device is safe and meets required standards.

On-demand clinical evaluation specialists  

The CER is often one of the most challenging aspects of the medical device regulatory process, requiring a high level of expertise and considerable investment of time and resources. However, as the expert economy grows, companies can now access highly-qualified specialists who can help them meet all the industry standards needed for approval.

The EU MDR regulation, which was previously supposed to be implemented in May 2020, was delayed by a year due to the pandemic and came into effect in May 2021. In that one year, a growing number of people left their jobs in search of better opportunities that offered flexibility. As research funding was cut, scientists around the world found themselves looking for alternative sources of income while also offering their expertise on an on-demand basis. Medical device businesses, who had worked traditionally until then, started hiring freelancers for one-off projects. Data from Kolabtree shows that from 2019-2021, there was an increase in the demand for clinical evaluation report writers in companies both big and small: and all of these jobs mentioned that the position was “work from home”.

Ashmita Das, CEO of Kolabtree, says, “Since the pandemic hit, medical device manufacturers have been adapting new and flexible ways of working. At Kolabtree, we are connecting medtech companies to a global pool of medical device experts, who can help with regulatory compliance, product development and medical writing. This helps businesses save costs and time, while accessing the expertise they need to push the boundaries of innovation.” The CER sample has been sourced from Kolabtree consultant Girish Hirpara, a CER expert and regulatory consultant with over 14 years of experience in the medical device industry.

Download the CER sample from the Kolabtree blog here.

Editors’ Note: Ramya Sriram is Senior Content Marketing Manager at Kolabtree, the world’s largest freelance platform for scientists and industry experts. 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”